HOME >> MEDICINE >> NEWS
NHLBI researchers find long-acting beta-agonists not as effective as inhaled corticosteroids in treating persistent asthma

Researchers supported by the National Heart, Lung, and Blood Institute (NHLBI) today report findings from two studies that address an ongoing controversy about whether long-acting beta-agonists (LABs) should replace or supplement inhaled corticosteroids (ICS) in the treatment of adults with mild-to-moderate persistent asthma.

The scientists found that using LABS alone is not as effective as using ICS alone in treating adults with mild-to-moderate persistent asthma. However, when LABS are used regularly to supplement treatment with ICS, they can improve asthma control and enable substantial reductions in steroid doses.

The two studies are "Long Acting Beta-Agonist Monotherapy vs. Continued Therapy with Inhaled Corticosteroids in Patients with Persistent Asthma" and "Inhaled Corticosteroid Reduction and Elimination in Patients with Persistent Asthma Receiving Salmeterol," and they appear in the May 23, 2000 issue of the Journal of the American Medical Association.

According to NHLBI Director Dr. Claude Lenfant, "These two studies provide new and important scientific information about treatment questions that clinicians face every day in managing adult patients with mild-to-moderate persistent asthma: can they switch patients to long-acting beta-agonists from inhaled corticosteroids or use long-acting beta-agonists to reduce steroid doses? Now we have the answer."

Asthma is a chronic lung disease that currently affects more than 15 million Americans, approximately 40 percent of whom have moderate persistent asthma. It is currently estimated to cost the U.S. economy $12.3 billion a year in health care costs and lost productivity.

Asthma is due to an inflammatory process in the bronchial air passages of the lungs that causes narrowing of the airways and, if untreated, may result in gradual loss of lung function. The NHLBI's "Guidelines for the Diagnosis and Management of Asthma" recommend that clinicians use daily an
'"/>

Contact: NHLBI Communications Office
sommere@nih.gov
301-496-4236
NIH/National Heart, Lung, and Blood Institute
21-May-2001


Page: 1 2 3

Related medicine news :

1. NHLBI study shows smoking cessation programs improve survival
2. Frequent fast food meals increase weight, diabetes risk, NHLBI study says
3. NHLBI statement on oral contraceptive study
4. NHLBI stops sickle cell anemia transfusion study
5. Statement from Barbara Alving of NHLBI on guidelines for cardiovascular disease prevention in women
6. Former NHLBI director Lenfant receives Lifetime Achievement Award
7. NHLBI study finds hostility, impatience increase hypertension risk
8. NHLBI study finds moderate physical activity promotes weight loss as well as intense exercise
9. NHLBI funds new heart-health education projects in high-risk communities
10. NHLBI study shows weight concerns increase girls risk of becoming smokers
11. NHLBI study shows vast majority of middle-aged Americans at risk of developing hypertension

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer ... physician colleagues, skilled nursing facility medical directors and other clinicians at various events ... Care." , "At many of these conferences we get to educate other physicians, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
Breaking Medicine Technology:
Cached News: